Aminosalicylate [EPC]

Aminosalicylate [EPC] was reported 100772 times

Drugs of the Aminosalicylate [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SYNOVIAL FLUID ANALYSIS 79 0.9080
1 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 304 0.9048
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 539 0.8069
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5714 0.7967
4 RED BLOOD CELL SEDIMENTATION RATE 212 0.7599
5 SWOLLEN JOINT COUNT INCREASED 2384 0.7469
6 LUPUS VULGARIS 941 0.7468
7 RHEUMATOID FACTOR POSITIVE 4221 0.7300
8 RHEUMATIC FEVER 3177 0.7120
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 1356 0.6770
10 HEPATIC ENZYME 100 0.6711
11 VAGINAL FLATULENCE 202 0.6667
12 CONGENITAL HIATUS HERNIA 150 0.6579
13 PEMPHIGUS 8199 0.6551
14 DUODENAL ULCER PERFORATION 4865 0.6535
15 GRIP STRENGTH 147 0.6419
16 C-REACTIVE PROTEIN 584 0.6300
17 GRANULOMA SKIN 506 0.6163
18 MUSCULOSKELETAL DEFORMITY 138 0.5897
19 HAND DEFORMITY 7667 0.5840
20 C-REACTIVE PROTEIN ABNORMAL 3666 0.5709
21 RHEUMATOID FACTOR NEGATIVE 98 0.5600
22 SWOLLEN JOINT COUNT 140 0.5600
23 FACET JOINT SYNDROME 1791 0.5496
24 X-RAY ABNORMAL 931 0.5201
25 SYNOVITIS 9366 0.5189
26 DISLOCATION OF VERTEBRA 1155 0.5059
27 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1049 0.5058
28 BODY HEIGHT BELOW NORMAL 316 0.4914
29 PRESBYACUSIS 148 0.4805
30 HELICOBACTER INFECTION 4935 0.4797
31 RETINITIS 825 0.4772
32 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1082 0.4692
33 SERONEGATIVE ARTHRITIS 529 0.4616
34 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 247 0.4403
35 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2862 0.4402
36 MUSCLE INJURY 3549 0.4279
37 BONE EROSION 1502 0.4243
38 BLOOD PARATHYROID HORMONE DECREASED 593 0.3999
39 HYPOCHOLESTEROLAEMIA 139 0.3938
40 FOLLICULITIS 4079 0.3886
41 PERICARDITIS 6254 0.3719
42 PERIPHERAL VENOUS DISEASE 1468 0.3591
43 GLOSSODYNIA 8047 0.3591
44 BLOOD IRON ABNORMAL 344 0.3521
45 DRUG TOLERANCE DECREASED 967 0.3440
46 MALIGNANT MELANOMA STAGE 0 71 0.3397
47 CONTRAINDICATED PRODUCT ADMINISTERED 9778 0.3226
48 ENTHESOPATHY 481 0.3073
49 INTESTINAL SEPSIS 76 0.2901
50 RHEUMATOID NODULE 760 0.2757
51 STEROID DEPENDENCE 238 0.2711
52 JOINT DESTRUCTION 413 0.2654
53 PANNICULITIS 641 0.2647
54 WOUND 7197 0.2572
55 SYSTEMIC LUPUS ERYTHEMATOSUS 9089 0.2558
56 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2665 0.2406
57 GRIP STRENGTH DECREASED 2108 0.2393
58 BREAST CANCER STAGE III 1533 0.2365
59 OVERLAP SYNDROME 159 0.2271
60 PORPHYRIA ACUTE 316 0.2202
61 TENOSYNOVITIS STENOSANS 120 0.2154
62 WRIST DEFORMITY 132 0.2146
63 NECK DEFORMITY 93 0.2095
64 ANKLE ARTHROPLASTY 75 0.2066
65 CATARRH 186 0.2058
66 SYNOVIAL DISORDER 93 0.2044
67 JOINT RANGE OF MOTION DECREASED 2744 0.2044
68 ONYCHOMADESIS 847 0.2016
69 DACTYLITIS 194 0.1976
70 LIP DRY 1794 0.1973
71 HYPERCHOLESTEROLAEMIA 1889 0.1954
72 IRRITABLE BOWEL SYNDROME 4143 0.1930
73 PLEURAL THICKENING 125 0.1827
74 JOINT ANKYLOSIS 103 0.1813
75 TENOSYNOVITIS 484 0.1753
76 WOUND INFECTION 1907 0.1740
77 BURSITIS 2102 0.1731
78 RHEUMATOID ARTHRITIS 19596 0.1724
79 ARTHROPATHY 9366 0.1683
80 ANTIBODY TEST POSITIVE 279 0.1680
81 ONYCHOMYCOSIS 733 0.1669
82 PLEURAL FIBROSIS 163 0.1600
83 MYOPERICARDITIS 123 0.1577
84 JUVENILE IDIOPATHIC ARTHRITIS 384 0.1569
85 THERAPEUTIC PRODUCT EFFECT DECREASED 7013 0.1564
86 DRUG SPECIFIC ANTIBODY 212 0.1547
87 FINGER DEFORMITY 730 0.1505
88 BLEPHAROSPASM 942 0.1495
89 PSORIATIC ARTHROPATHY 6068 0.1493
90 FIBROMYALGIA 3629 0.1491
91 LIVE BIRTH 1240 0.1481
92 DRUG INTOLERANCE 14235 0.1472
93 MEAN PLATELET VOLUME DECREASED 120 0.1430
94 AUTOIMMUNE DISORDER 1385 0.1419
95 FEMALE GENITAL TRACT FISTULA 242 0.1416
96 POLYARTHRITIS 744 0.1410
97 SPONDYLOARTHROPATHY 84 0.1400
98 VASCULAR ACCESS COMPLICATION 110 0.1358
99 IMPAIRED HEALING 4393 0.1337
100 LIVER INJURY 3238 0.1318
101 BLOOD MAGNESIUM INCREASED 117 0.1297
102 C-REACTIVE PROTEIN INCREASED 4714 0.1294
103 SOFT TISSUE SWELLING 73 0.1285
104 PROCTITIS 353 0.1259
105 EXOSTOSIS 1137 0.1244
106 NAIL DISORDER 1078 0.1231
107 SCIATICA 1942 0.1217
108 ARTHRODESIS 123 0.1208
109 DEATH NEONATAL 168 0.1207
110 BONE CYST 113 0.1205
111 OBESITY 1917 0.1202
112 INFUSION RELATED REACTION 7899 0.1191
113 BLOOD PRESSURE DIASTOLIC ABNORMAL 303 0.1190
114 COLITIS ULCERATIVE 5291 0.1183
115 THERAPEUTIC REACTION TIME DECREASED 344 0.1178
116 FOOT DEFORMITY 1305 0.1176
117 BLOOD PRESSURE SYSTOLIC ABNORMAL 284 0.1148
118 TYPE 2 DIABETES MELLITUS 3862 0.1146
119 TREATMENT FAILURE 9498 0.1145
120 INFUSION SITE REACTION 342 0.1144
121 RHEUMATOID LUNG 109 0.1141
122 INFLAMMATORY PAIN 77 0.1134
123 MATERNAL EXPOSURE TIMING UNSPECIFIED 423 0.1125
124 PULMONARY FIBROSIS 2126 0.1107
125 ALANINE AMINOTRANSFERASE ABNORMAL 230 0.1090
126 BURNS SECOND DEGREE 190 0.1082
127 HIP ARTHROPLASTY 1658 0.1081
128 JOINT SWELLING 12988 0.1075
129 HEPATIC ENZYME INCREASED 7293 0.1069
130 SKIN NECROSIS 538 0.1036
131 LUPUS-LIKE SYNDROME 924 0.1018
132 PUSTULAR PSORIASIS 347 0.1009
133 TRANSPLANT DYSFUNCTION 180 0.1008
134 DISCOMFORT 6109 0.1000
135 SACROILIITIS 188 0.0995
136 BLOODY DISCHARGE 113 0.0989
137 FAECAL CALPROTECTIN INCREASED 308 0.0972
138 APPARENT DEATH 350 0.0971
139 MUCOUS STOOLS 477 0.0962
140 RADICULOPATHY 252 0.0955
141 SWELLING 8947 0.0955
142 WALKING AID USER 608 0.0921
143 KNEE ARTHROPLASTY 1937 0.0919
144 OSTEOARTHRITIS 3890 0.0917
145 LOWER RESPIRATORY TRACT INFECTION 4165 0.0915
146 BONE SWELLING 87 0.0899
147 MUSCULOSKELETAL STIFFNESS 7717 0.0880
148 JOINT DISLOCATION 907 0.0857
149 MEAN CELL VOLUME DECREASED 132 0.0855
150 LOWER LIMB FRACTURE 1599 0.0831
151 SPONDYLITIS 301 0.0827
152 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3932 0.0818
153 FREQUENT BOWEL MOVEMENTS 2208 0.0817
154 BACK INJURY 886 0.0814
155 BLOOD CHOLESTEROL INCREASED 3797 0.0814
156 RECTAL TENESMUS 100 0.0803
157 MEAN CELL HAEMOGLOBIN DECREASED 147 0.0802
158 PRESCRIBED OVERDOSE 1536 0.0793
159 BLISTER 4456 0.0793
160 INFLAMMATION 4077 0.0789
161 DRUG TOLERANCE 398 0.0786
162 LIVER FUNCTION TEST INCREASED 1685 0.0784
163 JOINT ARTHROPLASTY 140 0.0781
164 PRODUCT LABEL CONFUSION 450 0.0771
165 CHRONIC SINUSITIS 288 0.0767
166 INTERNATIONAL NORMALISED RATIO FLUCTUATION 156 0.0753
167 STOMATITIS 4525 0.0745
168 GAIT INABILITY 2483 0.0742
169 JOINT EFFUSION 497 0.0720
170 JOINT STIFFNESS 1858 0.0708
171 BRONCHIECTASIS 475 0.0704
172 MOBILITY DECREASED 5057 0.0703
173 BONE MARROW OEDEMA 72 0.0695
174 SCLERITIS 110 0.0686
175 COELIAC DISEASE 672 0.0684
176 MATERNAL EXPOSURE DURING PREGNANCY 6066 0.0680
177 BREAST CANCER STAGE II 562 0.0675
178 LOSS OF THERAPEUTIC RESPONSE 215 0.0674
179 PRESCRIBED UNDERDOSE 1310 0.0656
180 ULCER HAEMORRHAGE 440 0.0650
181 PLEURITIC PAIN 178 0.0644
182 NIGHT SWEATS 2040 0.0632
183 ABDOMINAL DISCOMFORT 10557 0.0629
184 EYE INJURY 190 0.0625
185 INTENTIONAL PRODUCT USE ISSUE 5455 0.0622
186 DEFAECATION URGENCY 435 0.0620
187 RHEUMATIC DISORDER 119 0.0615
188 ANKYLOSING SPONDYLITIS 810 0.0614
189 WHEELCHAIR USER 273 0.0613
190 MALIGNANT MELANOMA IN SITU 76 0.0613
191 MUSCULOSKELETAL PAIN 3214 0.0613
192 SYNOVIAL CYST 283 0.0612
193 HEPATIC CIRRHOSIS 1146 0.0609
194 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4291 0.0603
195 CONGENITAL ANOMALY 461 0.0595
196 RASH VESICULAR 287 0.0593
197 TUBERCULIN TEST POSITIVE 150 0.0592
198 MACULAR DEGENERATION 691 0.0578
199 ILL-DEFINED DISORDER 3493 0.0574
200 SPINAL STENOSIS 237 0.0574
201 FINE MOTOR SKILL DYSFUNCTION 165 0.0570
202 BLOOD PRESSURE DIASTOLIC INCREASED 253 0.0548
203 HYPOPNOEA 190 0.0547
204 DISABILITY 1068 0.0540
205 DRUG LEVEL BELOW THERAPEUTIC 297 0.0538
206 BREATH SOUNDS ABNORMAL 265 0.0537
207 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 126 0.0531
208 CUSHINGOID 169 0.0526
209 HAEMATOCHEZIA 2882 0.0522
210 BASAL CELL CARCINOMA 811 0.0519
211 GASTROINTESTINAL DISORDER 4656 0.0519
212 LIMB DEFORMITY 82 0.0516
213 THERAPY NON-RESPONDER 2305 0.0512
214 LUNG DISORDER 2500 0.0510
215 OSTEOSCLEROSIS 80 0.0508
216 TENDERNESS 528 0.0506
217 HEPATIC ENZYME ABNORMAL 252 0.0505
218 WHEEZING 2992 0.0504
219 HYPERCALCAEMIA 621 0.0502
220 ALOPECIA 9871 0.0502
221 DEFORMITY 465 0.0497
222 ALCOHOL POISONING 132 0.0492
223 THYROID NEOPLASM 135 0.0489
224 ANTINUCLEAR ANTIBODY POSITIVE 159 0.0489
225 SPINAL FUSION SURGERY 196 0.0483
226 CREPITATIONS 143 0.0480
227 DEAFNESS NEUROSENSORY 157 0.0477
228 INJURY 3341 0.0475
229 ARTHRITIS 3728 0.0473
230 INVESTIGATION ABNORMAL 68 0.0473
231 ULCER 746 0.0468
232 BLADDER TRANSITIONAL CELL CARCINOMA 67 0.0468
233 CROHN'S DISEASE 320 0.0466
234 GENERAL PHYSICAL HEALTH DETERIORATION 5330 0.0460
235 PERIPHERAL SWELLING 7050 0.0457
236 NEOPLASM SKIN 71 0.0457
237 PULMONARY TOXICITY 323 0.0456
238 ADRENAL INSUFFICIENCY 554 0.0456
239 PREGNANCY 912 0.0455
240 MONOCYTE COUNT INCREASED 165 0.0454
241 IRON DEFICIENCY 204 0.0453
242 SLEEP DISORDER 3176 0.0450
243 LIVER DISORDER 1987 0.0448
244 TASTE DISORDER 904 0.0445
245 NECK MASS 126 0.0445
246 DRUG SPECIFIC ANTIBODY PRESENT 289 0.0444
247 ANAL FISSURE 238 0.0443
248 BLOOD PRESSURE DIASTOLIC DECREASED 324 0.0438
249 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 751 0.0438
250 SINUSITIS 4469 0.0436
251 NODULE 568 0.0435
252 HYPERSENSITIVITY 8003 0.0431
253 HEPATITIS 1102 0.0430
254 DRUG-INDUCED LIVER INJURY 1343 0.0428
255 INFLAMMATORY MARKER INCREASED 211 0.0425
256 ROAD TRAFFIC ACCIDENT 1776 0.0424
257 ILEAL STENOSIS 75 0.0422
258 INFECTION 6067 0.0419
259 IMMOBILE 183 0.0419
260 NORMAL NEWBORN 227 0.0417
261 CYTOMEGALOVIRUS COLITIS 96 0.0417
262 EPIGASTRIC DISCOMFORT 163 0.0417
263 OEDEMA 2245 0.0414
264 DIARRHOEA HAEMORRHAGIC 383 0.0409
265 COLITIS MICROSCOPIC 194 0.0409
266 RECTAL HAEMORRHAGE 1753 0.0408
267 CONDITION AGGRAVATED 12404 0.0408
268 DRUG ERUPTION 721 0.0406
269 BLOOD PRESSURE FLUCTUATION 959 0.0399
270 SERUM FERRITIN DECREASED 69 0.0399
271 DRUG LEVEL DECREASED 402 0.0395
272 SKIN ULCER 1021 0.0395
273 CHOLANGITIS SCLEROSING 79 0.0384
274 LYME DISEASE 128 0.0384
275 DIVERTICULITIS 1064 0.0384
276 BLOOD PRESSURE SYSTOLIC INCREASED 745 0.0382
277 GASTROINTESTINAL TOXICITY 183 0.0381
278 WHITE BLOOD CELL COUNT ABNORMAL 243 0.0380
279 CONTUSION 3638 0.0378
280 OSTEOPOROSIS 1532 0.0372
281 BODY TEMPERATURE DECREASED 366 0.0371
282 ANAL FISTULA 198 0.0371
283 TONGUE DISORDER 267 0.0369
284 DRUG LEVEL ABOVE THERAPEUTIC 168 0.0366
285 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 119 0.0366
286 ADVERSE REACTION 483 0.0364
287 EXPOSURE DURING PREGNANCY 2260 0.0363
288 LATENT TUBERCULOSIS 76 0.0363
289 FOOD INTOLERANCE 132 0.0360
290 PHYSICAL DISABILITY 159 0.0359
291 HEPATOTOXICITY 793 0.0356
292 ANAL ABSCESS 191 0.0354
293 ARTHRALGIA 14671 0.0352
294 GRANULOMA 122 0.0352
295 SHOULDER ARTHROPLASTY 94 0.0349
296 IMPAIRED WORK ABILITY 743 0.0347
297 FEAR OF INJECTION 247 0.0346
298 RHINITIS 279 0.0346
299 JOINT INJURY 738 0.0345
300 ANAL HAEMORRHAGE 96 0.0342
301 DELIRIUM 1188 0.0342
302 BENIGN PROSTATIC HYPERPLASIA 176 0.0340
303 POOR VENOUS ACCESS 351 0.0339
304 FAECES SOFT 244 0.0335
305 BONE DENSITY ABNORMAL 125 0.0334
306 NASOPHARYNGITIS 6161 0.0334
307 PRODUCT USE ISSUE 6258 0.0333
308 UVEITIS 446 0.0328
309 EAR INFECTION 870 0.0327
310 NECK PAIN 1827 0.0327
311 RED CELL DISTRIBUTION WIDTH INCREASED 134 0.0322
312 DERMATITIS PSORIASIFORM 65 0.0318
313 MYOSITIS 283 0.0315
314 EPILEPSY 964 0.0315
315 PYODERMA GANGRENOSUM 113 0.0314
316 IMMUNODEFICIENCY 463 0.0310
317 MATERNAL EXPOSURE DURING BREAST FEEDING 126 0.0310
318 DRY MOUTH 2503 0.0308
319 ERYTHEMA NODOSUM 107 0.0304
320 EAR PAIN 584 0.0300
321 HEPATIC FIBROSIS 103 0.0300
322 ORAL CANDIDIASIS 395 0.0300
323 SUSPECTED OFF LABEL USE 134 0.0296
324 GENERAL SYMPTOM 221 0.0295
325 TENDONITIS 454 0.0293
326 ARTHRITIS BACTERIAL 118 0.0287
327 DYSPEPSIA 2826 0.0287
328 MUSCULOSKELETAL DISORDER 544 0.0286
329 ENDOMETRIOSIS 136 0.0285
330 COLITIS 1075 0.0283
331 IMPAIRED QUALITY OF LIFE 405 0.0281
332 LARGE INTESTINE POLYP 194 0.0280
333 PAROSMIA 210 0.0278
334 PAIN 17090 0.0278
335 RESPIRATORY SYMPTOM 79 0.0277
336 WEIGHT FLUCTUATION 290 0.0277
337 DEMYELINATION 113 0.0275
338 TERMINAL STATE 184 0.0275
339 HYPERTENSION 5781 0.0273
340 LARGE INTESTINAL ULCER 74 0.0272
341 GINGIVAL PAIN 215 0.0270
342 WEIGHT INCREASED 6027 0.0269
343 CYST 334 0.0269
344 OVARIAN CYST 268 0.0268
345 APHTHOUS ULCER 207 0.0267
346 CONFUSIONAL STATE 4307 0.0266
347 RASH 11548 0.0265
348 CARDIAC MURMUR 229 0.0264
349 INTERSTITIAL LUNG DISEASE 1278 0.0264
350 DERMATITIS ALLERGIC 331 0.0263
351 THERAPEUTIC RESPONSE DECREASED 1589 0.0262
352 CLOSTRIDIUM DIFFICILE INFECTION 572 0.0262
353 PULMONARY THROMBOSIS 281 0.0257
354 FOOT OPERATION 127 0.0256
355 HYPOAESTHESIA 3840 0.0256
356 MIGRAINE 2440 0.0255
357 ARTHRITIS INFECTIVE 117 0.0252
358 DRUG INEFFECTIVE 33183 0.0252
359 PULMONARY MASS 375 0.0251
360 INFLAMMATORY BOWEL DISEASE 246 0.0251
361 IRITIS 75 0.0246
362 PROCTALGIA 158 0.0245
363 MATERNAL EXPOSURE BEFORE PREGNANCY 167 0.0244
364 BACK DISORDER 389 0.0239
365 CARPAL TUNNEL SYNDROME 332 0.0237
366 TONGUE ULCERATION 80 0.0237
367 DYSLIPIDAEMIA 120 0.0236
368 URTICARIA 3928 0.0234
369 SENSITIVITY TO WEATHER CHANGE 123 0.0234
370 TUBULOINTERSTITIAL NEPHRITIS 437 0.0233
371 THROMBOCYTOSIS 85 0.0232
372 HEPATIC STEATOSIS 432 0.0232
373 TRANSPLANT REJECTION 184 0.0229
374 PULMONARY TUBERCULOSIS 98 0.0229
375 VAGINAL DISCHARGE 231 0.0228
376 OSTEOPENIA 343 0.0226
377 FISTULA 254 0.0226
378 PLATELET COUNT INCREASED 294 0.0225
379 PAIN IN EXTREMITY 6516 0.0221
380 MOUTH ULCERATION 461 0.0219
381 DYSCHEZIA 66 0.0216
382 HEART RATE DECREASED 756 0.0215
383 BLOOD IRON DECREASED 255 0.0215
384 UPPER RESPIRATORY TRACT INFECTION 992 0.0214
385 ADVERSE DRUG REACTION 1924 0.0214
386 ADVERSE EVENT 1972 0.0214
387 RESPIRATORY DISORDER 638 0.0213
388 GASTROINTESTINAL INFLAMMATION 167 0.0213
389 MULTIPLE ALLERGIES 167 0.0213
390 THERAPEUTIC RESPONSE SHORTENED 706 0.0213
391 LOCALISED INFECTION 512 0.0212
392 LIVER FUNCTION TEST ABNORMAL 612 0.0210
393 RASH PRURITIC 1126 0.0208
394 GASTROOESOPHAGEAL REFLUX DISEASE 1656 0.0206
395 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 348 0.0205
396 SPINAL OSTEOARTHRITIS 179 0.0204
397 ALANINE AMINOTRANSFERASE INCREASED 1245 0.0203
398 MUSCULOSKELETAL DISCOMFORT 346 0.0201
399 PSORIASIS 2599 0.0199
400 PARAESTHESIA ORAL 287 0.0199
401 HERPES ZOSTER 1134 0.0197
402 OFF LABEL USE 17125 0.0195
403 SPINAL PAIN 228 0.0194
404 FATIGUE 15130 0.0194
405 DRUG EFFECT INCOMPLETE 702 0.0193
406 PYREXIA 6663 0.0192
407 MEDICATION ERROR 1069 0.0192
408 LYMPHOMA 297 0.0192
409 GAIT DISTURBANCE 3673 0.0192
410 ONYCHOCLASIS 132 0.0192
411 GASTROINTESTINAL PAIN 211 0.0192
412 BONE LESION 69 0.0191
413 ABDOMINAL PAIN 4450 0.0191
414 ESCHERICHIA URINARY TRACT INFECTION 81 0.0190
415 MENISCUS INJURY 117 0.0190
416 MYOCARDITIS 218 0.0190
417 HAEMORRHOIDS 371 0.0190
418 AMNESIA 1232 0.0189
419 TOOTH INFECTION 249 0.0189
420 ROTATOR CUFF SYNDROME 242 0.0188
421 ABSCESS 300 0.0188
422 ABDOMINAL PAIN UPPER 3842 0.0186
423 ASTHMA 2088 0.0185
424 ANAL INCONTINENCE 163 0.0181
425 SARCOIDOSIS 86 0.0181
426 ABNORMAL FAECES 147 0.0179
427 ASPARTATE AMINOTRANSFERASE INCREASED 952 0.0179
428 GASTROINTESTINAL INFECTION 160 0.0178
429 PHOTOSENSITIVITY REACTION 294 0.0178
430 CANDIDA INFECTION 299 0.0177
431 ORAL DISCOMFORT 246 0.0177
432 BRONCHITIS 1307 0.0176
433 FULL BLOOD COUNT ABNORMAL 186 0.0176
434 INTESTINAL STENOSIS 74 0.0175
435 ANORECTAL DISCOMFORT 93 0.0175
436 LIMB DISCOMFORT 541 0.0175
437 HYPERTRANSAMINASAEMIA 121 0.0174
438 ATELECTASIS 168 0.0174
439 TRIGGER FINGER 71 0.0174
440 GASTROENTERITIS VIRAL 311 0.0172
441 SKIN REACTION 241 0.0171
442 SUBCUTANEOUS ABSCESS 82 0.0171
443 BOWEL MOVEMENT IRREGULARITY 130 0.0170
444 INJECTION SITE REACTION 1159 0.0168
445 FOOT FRACTURE 319 0.0168
446 THERAPEUTIC PRODUCT EFFECT DELAYED 76 0.0166
447 SKIN LACERATION 181 0.0166
448 SECRETION DISCHARGE 208 0.0166
449 PNEUMONIA 5366 0.0166
450 MUSCULAR WEAKNESS 1868 0.0164
451 FLANK PAIN 154 0.0164
452 GOITRE 67 0.0163
453 ANAPHYLACTIC REACTION 903 0.0163
454 MALIGNANT MELANOMA 218 0.0163
455 SPUTUM DISCOLOURED 154 0.0162
456 INCORRECT DOSAGE ADMINISTERED 79 0.0161
457 ORGANISING PNEUMONIA 80 0.0161
458 POSTOPERATIVE WOUND INFECTION 109 0.0161
459 BLOOD ALBUMIN DECREASED 128 0.0161
460 IMMUNOSUPPRESSION 142 0.0161
461 TONSILLITIS 84 0.0161
462 WEIGHT DECREASED 4427 0.0158
463 GASTRIC DISORDER 544 0.0158
464 PANCREATITIS 837 0.0158
465 TOOTH ABSCESS 161 0.0158
466 MALAISE 6877 0.0157
467 VITAMIN D DECREASED 134 0.0157
468 INFUSION SITE EXTRAVASATION 97 0.0156
469 PYELONEPHRITIS 135 0.0156
470 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2790 0.0155
471 PURULENT DISCHARGE 66 0.0154
472 NEPHROLITHIASIS 707 0.0154
473 MICTURITION URGENCY 176 0.0154
474 IRON DEFICIENCY ANAEMIA 142 0.0154
475 WHITE BLOOD CELL COUNT INCREASED 589 0.0153
476 PHARYNGITIS 190 0.0153
477 OSTEOMYELITIS 277 0.0153
478 INTERVERTEBRAL DISC DEGENERATION 141 0.0152
479 THERAPY PARTIAL RESPONDER 237 0.0152
480 CHEST PAIN 2799 0.0151
481 LABORATORY TEST ABNORMAL 441 0.0149
482 ATRIOVENTRICULAR BLOCK COMPLETE 100 0.0149
483 ABDOMINAL ABSCESS 66 0.0149
484 SKIN LESION 408 0.0149
485 DECREASED APPETITE 3453 0.0149
486 SEPTIC SHOCK 645 0.0148
487 TENDON DISORDER 96 0.0147
488 GROIN PAIN 129 0.0147
489 GLAUCOMA 282 0.0146
490 SKIN WARM 85 0.0146
491 MEMORY IMPAIRMENT 2005 0.0146
492 BONE DENSITY DECREASED 453 0.0144
493 HAEMATOCRIT DECREASED 286 0.0144
494 OEDEMA PERIPHERAL 1751 0.0144
495 LIGAMENT SPRAIN 142 0.0143
496 APPENDICITIS 134 0.0143
497 COLECTOMY 81 0.0143
498 VARICOSE VEIN 74 0.0143
499 PRODUCT USE IN UNAPPROVED INDICATION 3541 0.0143
500 DEEP VEIN THROMBOSIS 927 0.0143
501 SPINAL DISORDER 135 0.0142
502 MENINGITIS 95 0.0142
503 VOMITING 6675 0.0142
504 THYROID DISORDER 217 0.0141
505 DIVERTICULUM 100 0.0141
506 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 71 0.0140
507 PARAESTHESIA 2204 0.0140
508 VASCULITIS 163 0.0140
509 PRURITUS 5373 0.0140
510 INGUINAL HERNIA 85 0.0140
511 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 359 0.0139
512 POLYP 91 0.0139
513 INSOMNIA 3701 0.0139
514 MUSCLE STRAIN 120 0.0139
515 LEUKOPENIA 692 0.0138
516 DIARRHOEA 8849 0.0137
517 LYMPHADENOPATHY 480 0.0135
518 HERNIA 262 0.0135
519 BEDRIDDEN 178 0.0135
520 SKIN PLAQUE 114 0.0135
521 HEADACHE 8463 0.0135
522 BODY TEMPERATURE INCREASED 275 0.0135
523 RALES 78 0.0134
524 DYSSTASIA 392 0.0134
525 TRANSAMINASES INCREASED 298 0.0134
526 ANKLE FRACTURE 206 0.0133
527 VISUAL IMPAIRMENT 1649 0.0133
528 GASTROENTERITIS 194 0.0133
529 SKIN INFECTION 149 0.0133
530 PROCEDURAL PAIN 368 0.0133
531 FURUNCLE 105 0.0132
532 DEPRESSION 3004 0.0132
533 CATARACT 786 0.0132
534 PRODUCT RESIDUE PRESENT 71 0.0132
535 POST PROCEDURAL INFECTION 107 0.0131
536 MUSCLE SPASMS 2409 0.0131
537 BLOOD TEST ABNORMAL 184 0.0131
538 PRODUCTIVE COUGH 622 0.0130
539 SWELLING OF EYELID 81 0.0129
540 QUALITY OF LIFE DECREASED 172 0.0128
541 ORAL HERPES 250 0.0128
542 FEELING HOT 785 0.0128
543 ABDOMINAL DISTENSION 1336 0.0128
544 NAUSEA 10101 0.0127
545 PREMATURE LABOUR 72 0.0127
546 BLOOD PRESSURE INCREASED 1932 0.0126
547 EYE INFECTION 142 0.0126
548 UNDERDOSE 911 0.0125
549 UROSEPSIS 115 0.0125
550 MOVEMENT DISORDER 398 0.0124
551 OXYGEN SATURATION DECREASED 694 0.0123
552 DECREASED IMMUNE RESPONSIVENESS 120 0.0122
553 MUSCLE SPASTICITY 150 0.0122
554 DIFFUSE LARGE B-CELL LYMPHOMA 94 0.0122
555 EYE DISORDER 401 0.0122
556 PHARYNGITIS STREPTOCOCCAL 132 0.0122
557 HIP SURGERY 66 0.0122
558 OROPHARYNGEAL PAIN 1123 0.0121
559 INTESTINAL PERFORATION 136 0.0121
560 RED BLOOD CELL COUNT DECREASED 346 0.0121
561 HYPOCALCAEMIA 229 0.0121
562 NERVE COMPRESSION 111 0.0120
563 RENAL CYST 95 0.0119
564 NEOPLASM MALIGNANT 798 0.0119
565 SINUS HEADACHE 71 0.0119
566 HEART RATE IRREGULAR 270 0.0119
567 RESPIRATORY RATE INCREASED 106 0.0119
568 AFFECTIVE DISORDER 93 0.0118
569 LARGE INTESTINE PERFORATION 82 0.0118
570 BACTERIAL INFECTION 220 0.0118
571 INTERVERTEBRAL DISC PROTRUSION 257 0.0117
572 RESPIRATORY TRACT INFECTION 306 0.0117
573 INFLUENZA 1293 0.0116
574 PNEUMOCYSTIS JIROVECII PNEUMONIA 115 0.0114
575 BACK PAIN 2651 0.0114
576 HIDRADENITIS 104 0.0114
577 SKIN DISORDER 380 0.0114
578 DRUG EFFECT DECREASED 612 0.0114
579 PLEURISY 67 0.0113
580 ABDOMINAL PAIN LOWER 285 0.0113
581 ASTHENIA 4229 0.0112
582 PNEUMONITIS 305 0.0112
583 PULMONARY EMBOLISM 1061 0.0112
584 IMMUNE SYSTEM DISORDER 146 0.0111
585 PHOTOPHOBIA 208 0.0110
586 MYASTHENIA GRAVIS 89 0.0110
587 CONJUNCTIVITIS 204 0.0110
588 DRY EYE 546 0.0109
589 HYPOALBUMINAEMIA 85 0.0109
590 CYSTITIS 348 0.0109
591 CELLULITIS 549 0.0109
592 BREAST MASS 73 0.0109
593 FOETAL GROWTH RESTRICTION 66 0.0108
594 OBSTRUCTIVE AIRWAYS DISORDER 120 0.0108
595 LIMB INJURY 293 0.0108
596 NASAL CONGESTION 632 0.0107
597 PRE-EXISTING CONDITION IMPROVED 67 0.0107
598 SQUAMOUS CELL CARCINOMA 101 0.0107
599 FEEDING DISORDER 217 0.0107
600 DYSPNOEA 6051 0.0107
601 LIPASE INCREASED 81 0.0106
602 SWOLLEN TONGUE 330 0.0106
603 STENT PLACEMENT 85 0.0105
604 SARS-COV-2 TEST POSITIVE 139 0.0105
605 RESPIRATORY TRACT CONGESTION 167 0.0105
606 COVID-19 1837 0.0105
607 PAIN IN JAW 296 0.0104
608 TENDON RUPTURE 129 0.0104
609 THROMBOSIS 839 0.0104
610 FUNGAL INFECTION 346 0.0104
611 PRODUCT AVAILABILITY ISSUE 235 0.0103
612 HAEMOGLOBIN DECREASED 1059 0.0103
613 PELVIC FRACTURE 80 0.0103
614 DERMATITIS 214 0.0102
615 HAND FRACTURE 72 0.0102
616 RHINORRHOEA 656 0.0101
617 MUSCULOSKELETAL CHEST PAIN 157 0.0101
618 INJECTION SITE IRRITATION 129 0.0101
619 NEUTROPENIC SEPSIS 72 0.0101
620 SINUS CONGESTION 136 0.0101
621 GASTRIC ULCER 190 0.0100
622 TROPONIN INCREASED 76 0.0100
623 DIZZINESS 4979 0.0100
624 ESCHERICHIA INFECTION 82 0.0100
625 AUTOIMMUNE HEPATITIS 69 0.0099
626 TOOTH DISORDER 220 0.0099
627 CYTOMEGALOVIRUS INFECTION 164 0.0099
628 NEUTROPHIL COUNT INCREASED 101 0.0099
629 ASPIRATION 108 0.0099
630 SEASONAL ALLERGY 139 0.0098
631 CLOSTRIDIUM DIFFICILE COLITIS 104 0.0098
632 INTESTINAL OBSTRUCTION 368 0.0098
633 HYPOPHOSPHATAEMIA 72 0.0097
634 DIABETES MELLITUS 742 0.0097
635 HYPERLIPIDAEMIA 116 0.0097
636 BLOOD CREATININE INCREASED 632 0.0097
637 HEART RATE INCREASED 953 0.0096
638 MASS 134 0.0096
639 LYMPHOEDEMA 66 0.0095
640 TACHYCARDIA 846 0.0095
641 ARTHROPOD BITE 70 0.0094
642 SPINAL COMPRESSION FRACTURE 78 0.0094
643 VITAMIN D DEFICIENCY 92 0.0094
644 DRUG EFFECT LESS THAN EXPECTED 139 0.0094
645 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 70 0.0093
646 STAPHYLOCOCCAL INFECTION 307 0.0093
647 FLATULENCE 527 0.0093
648 MUCOSAL INFLAMMATION 243 0.0093
649 ECZEMA 485 0.0093
650 PANCREATITIS ACUTE 208 0.0092
651 ERYTHEMA 1895 0.0092
652 UTERINE LEIOMYOMA 67 0.0092
653 HYPOKINESIA 133 0.0092
654 VIRAL INFECTION 304 0.0091
655 ORAL PAIN 204 0.0091
656 BONE DISORDER 166 0.0091
657 FRUSTRATION TOLERANCE DECREASED 73 0.0090
658 DRUG RESISTANCE 231 0.0090
659 KIDNEY INFECTION 176 0.0090
660 SPLENOMEGALY 105 0.0090
661 ILLNESS 922 0.0089
662 CORONARY ARTERY DISEASE 271 0.0089
663 COUGH 2507 0.0089
664 BLOOD POTASSIUM INCREASED 145 0.0089
665 POOR QUALITY SLEEP 192 0.0089
666 EYE INFLAMMATION 85 0.0089
667 PLEURAL EFFUSION 542 0.0089
668 COVID-19 PNEUMONIA 105 0.0089
669 UPPER-AIRWAY COUGH SYNDROME 73 0.0089
670 SEPSIS 986 0.0088
671 FLUID RETENTION 446 0.0088
672 INFLUENZA LIKE ILLNESS 721 0.0088
673 BLOOD PRESSURE ABNORMAL 173 0.0087
674 FAECES DISCOLOURED 187 0.0086
675 NEURALGIA 209 0.0086
676 HAEMOLYTIC ANAEMIA 77 0.0086
677 HYPOKALAEMIA 395 0.0085
678 TINNITUS 392 0.0085
679 SMALL INTESTINAL OBSTRUCTION 105 0.0085
680 WRIST FRACTURE 102 0.0085
681 INJECTION SITE HAEMATOMA 123 0.0085
682 VERTIGO 516 0.0085
683 FOETAL EXPOSURE DURING PREGNANCY 687 0.0084
684 MULTIPLE FRACTURES 138 0.0084
685 DISEASE RECURRENCE 398 0.0084
686 INTENTIONAL DOSE OMISSION 238 0.0083
687 BLOOD CALCIUM INCREASED 73 0.0083
688 TOOTH FRACTURE 91 0.0082
689 COLON CANCER 122 0.0082
690 SKIN CANCER 176 0.0082
691 SCRATCH 86 0.0081
692 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 424 0.0081
693 CHOLELITHIASIS 266 0.0081
694 ANXIETY 2306 0.0081
695 TOOTHACHE 146 0.0081
696 DYSPNOEA EXERTIONAL 303 0.0080
697 FEELING JITTERY 153 0.0080
698 CYTOPENIA 98 0.0080
699 IMPAIRED GASTRIC EMPTYING 109 0.0080
700 URINARY TRACT INFECTION 1358 0.0080
701 RASH MACULO-PAPULAR 177 0.0079
702 HIATUS HERNIA 103 0.0079
703 BODY HEIGHT DECREASED 84 0.0078
704 PNEUMONIA BACTERIAL 72 0.0078
705 EMPHYSEMA 79 0.0078
706 TREATMENT NONCOMPLIANCE 427 0.0078
707 ACCIDENT 93 0.0078
708 GASTRITIS 204 0.0077
709 RIB FRACTURE 159 0.0077
710 INJECTION SITE EXTRAVASATION 95 0.0077
711 HYPERTENSIVE CRISIS 85 0.0076
712 GOUT 137 0.0076
713 CHILLS 895 0.0076
714 HYSTERECTOMY 66 0.0076
715 AFFECT LABILITY 73 0.0076
716 EOSINOPHILIA 132 0.0075
717 SWELLING FACE 486 0.0075
718 FALL 2475 0.0074
719 ILEUS 92 0.0074
720 HYPOTHYROIDISM 235 0.0074
721 TRANSIENT ISCHAEMIC ATTACK 248 0.0073
722 LUNG INFECTION 114 0.0073
723 MALNUTRITION 82 0.0073
724 INSURANCE ISSUE 111 0.0073
725 PANCYTOPENIA 404 0.0072
726 RASH ERYTHEMATOUS 345 0.0072
727 PALPITATIONS 838 0.0071
728 LEUKOCYTOSIS 129 0.0071
729 PNEUMOTHORAX 112 0.0071
730 LYMPHOCYTE COUNT DECREASED 124 0.0070
731 ANAEMIA 1337 0.0070
732 NIGHTMARE 240 0.0069
733 UPPER LIMB FRACTURE 138 0.0069
734 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 379 0.0069
735 LOSS OF CONSCIOUSNESS 884 0.0069
736 PRODUCT QUALITY ISSUE 936 0.0069
737 DEAFNESS 179 0.0068
738 INFUSION SITE PAIN 88 0.0068
739 MITRAL VALVE INCOMPETENCE 77 0.0068
740 PERICARDIAL EFFUSION 157 0.0068
741 RENAL IMPAIRMENT 565 0.0067
742 GALLBLADDER DISORDER 120 0.0067
743 POST PROCEDURAL COMPLICATION 128 0.0067
744 INTRAOCULAR PRESSURE INCREASED 85 0.0066
745 SNEEZING 149 0.0066
746 BLOOD URINE PRESENT 126 0.0066
747 EJECTION FRACTION DECREASED 103 0.0066
748 SCAR 113 0.0066
749 MOTOR DYSFUNCTION 67 0.0066
750 CHOLECYSTECTOMY 75 0.0066
751 ACNE 495 0.0065
752 GASTRIC HAEMORRHAGE 75 0.0065
753 BURNING SENSATION 455 0.0065
754 ACCIDENTAL OVERDOSE 237 0.0065
755 RENAL FAILURE 860 0.0065
756 CARDIOVASCULAR DISORDER 164 0.0065
757 INJECTION SITE PRURITUS 430 0.0064
758 SPINAL OPERATION 79 0.0064
759 SCAB 73 0.0064
760 ANGIOEDEMA 283 0.0064
761 RENAL DISORDER 295 0.0063
762 TOOTH LOSS 131 0.0063
763 OESOPHAGITIS 69 0.0063
764 APHONIA 88 0.0063
765 FRACTURE 119 0.0063
766 TOXIC EPIDERMAL NECROLYSIS 95 0.0062
767 BRONCHOSPASM 89 0.0062
768 PALLOR 169 0.0062
769 NEUROPATHY PERIPHERAL 588 0.0062
770 BRAIN FOG 96 0.0061
771 FEELING COLD 170 0.0061
772 DYSPHONIA 357 0.0061
773 CAESAREAN SECTION 71 0.0061
774 FEMUR FRACTURE 188 0.0061
775 CONSTIPATION 1319 0.0060
776 INJECTION SITE WARMTH 124 0.0060
777 AGRANULOCYTOSIS 112 0.0060
778 GAMMA-GLUTAMYLTRANSFERASE INCREASED 132 0.0060
779 INCORRECT PRODUCT ADMINISTRATION DURATION 129 0.0059
780 HEAD DISCOMFORT 105 0.0059
781 THROAT IRRITATION 266 0.0059
782 WHITE BLOOD CELL COUNT DECREASED 641 0.0059
783 MYALGIA 1001 0.0059
784 BLOOD ALKALINE PHOSPHATASE INCREASED 146 0.0059
785 PRODUCT PRESCRIBING ERROR 140 0.0059
786 BLOOD PRESSURE DECREASED 390 0.0059
787 SLEEP APNOEA SYNDROME 112 0.0059
788 END STAGE RENAL DISEASE 106 0.0058
789 CORONARY ARTERY OCCLUSION 79 0.0058
790 BREAST CANCER 536 0.0057
791 THYROID CANCER 69 0.0057
792 CARDIOMYOPATHY 84 0.0057
793 POLYNEUROPATHY 68 0.0057
794 HYPOPHAGIA 145 0.0057
795 PELVIC PAIN 103 0.0057
796 SKIN DISCOLOURATION 260 0.0057
797 SYNCOPE 566 0.0057
798 CHOLECYSTITIS 67 0.0056
799 STEVENS-JOHNSON SYNDROME 125 0.0056
800 MOOD SWINGS 179 0.0056
801 CRYING 203 0.0056
802 GENERALISED OEDEMA 69 0.0056
803 RASH MACULAR 194 0.0055
804 INJECTION SITE SWELLING 422 0.0055
805 BACTERAEMIA 65 0.0055
806 ABORTION SPONTANEOUS 219 0.0055
807 RASH PAPULAR 122 0.0054
808 PROTEINURIA 103 0.0054
809 FEELING ABNORMAL 1289 0.0054
810 LIP SWELLING 179 0.0054
811 SKIN FISSURES 105 0.0054
812 INJECTION SITE DISCOLOURATION 67 0.0054
813 MIDDLE INSOMNIA 100 0.0053
814 EATING DISORDER 114 0.0053
815 INJECTION SITE BRUISING 426 0.0053
816 MUSCLE TIGHTNESS 86 0.0053
817 SINUS DISORDER 105 0.0053
818 CARDIOMEGALY 65 0.0053
819 PREMATURE BABY 158 0.0052
820 BLOOD POTASSIUM DECREASED 156 0.0052
821 MELAENA 114 0.0052
822 OCULAR HYPERAEMIA 245 0.0052
823 CHROMATURIA 115 0.0051
824 ANGINA PECTORIS 145 0.0051
825 LOCAL SWELLING 88 0.0050
826 HOSPITALISATION 775 0.0050
827 PRESYNCOPE 122 0.0050
828 SOMNOLENCE 1010 0.0050
829 LYMPHOPENIA 70 0.0049
830 HAEMOPTYSIS 138 0.0049
831 MULTIPLE ORGAN DYSFUNCTION SYNDROME 140 0.0049
832 FACE OEDEMA 83 0.0049
833 UNEVALUABLE EVENT 371 0.0049
834 SPINAL FRACTURE 98 0.0049
835 CHEST DISCOMFORT 500 0.0049
836 INJECTION SITE ERYTHEMA 598 0.0048
837 BLOOD LACTATE DEHYDROGENASE INCREASED 76 0.0048
838 HEAD INJURY 151 0.0048
839 THROAT TIGHTNESS 129 0.0048
840 EYE PAIN 269 0.0048
841 PHARYNGEAL OEDEMA 73 0.0047
842 HAEMORRHAGE 495 0.0047
843 CHRONIC KIDNEY DISEASE 357 0.0047
844 HYPOTENSION 929 0.0046
845 INJECTION SITE RASH 142 0.0046
846 INJECTION SITE PAIN 1404 0.0046
847 LETHARGY 263 0.0046
848 BLOOD SODIUM DECREASED 86 0.0046
849 EMOTIONAL DISORDER 140 0.0045
850 FEAR 122 0.0045
851 JAUNDICE 122 0.0045
852 DRUG LEVEL INCREASED 75 0.0045
853 INJECTION SITE URTICARIA 111 0.0045
854 DEHYDRATION 598 0.0045
855 DYSGEUSIA 333 0.0045
856 INCORRECT DOSE ADMINISTERED 1022 0.0045
857 HAEMATEMESIS 113 0.0045
858 HYPERHIDROSIS 574 0.0045
859 ACTIVITIES OF DAILY LIVING IMPAIRED 88 0.0044
860 INTENTIONAL PRODUCT MISUSE 389 0.0044
861 THROMBOCYTOPENIA 494 0.0044
862 MENTAL DISORDER 192 0.0044
863 PREMATURE DELIVERY 70 0.0044
864 DYSURIA 161 0.0044
865 DEPRESSED MOOD 231 0.0044
866 LUNG NEOPLASM MALIGNANT 179 0.0044
867 PULMONARY OEDEMA 194 0.0043
868 MYOCARDIAL INFARCTION 746 0.0043
869 EYE SWELLING 159 0.0043
870 INJECTION SITE HAEMORRHAGE 340 0.0043
871 ACUTE MYOCARDIAL INFARCTION 125 0.0042
872 BREAST CANCER FEMALE 113 0.0042
873 UPPER GASTROINTESTINAL HAEMORRHAGE 69 0.0041
874 RESPIRATORY FAILURE 297 0.0041
875 DRUG INTERACTION 646 0.0041
876 HYPONATRAEMIA 229 0.0041
877 SURGERY 237 0.0040
878 ANAPHYLACTIC SHOCK 104 0.0040
879 ASCITES 118 0.0040
880 FLUSHING 407 0.0040
881 BALANCE DISORDER 340 0.0039
882 NEUTROPENIA 534 0.0039
883 BONE PAIN 230 0.0039
884 PRODUCT DOSE OMISSION ISSUE 1154 0.0039
885 POLLAKIURIA 163 0.0039
886 NERVOUS SYSTEM DISORDER 121 0.0039
887 ACUTE RESPIRATORY DISTRESS SYNDROME 68 0.0038
888 GASTROINTESTINAL HAEMORRHAGE 319 0.0038
889 COLD SWEAT 67 0.0038
890 ARRHYTHMIA 180 0.0038
891 ACUTE RESPIRATORY FAILURE 73 0.0038
892 HIP FRACTURE 122 0.0038
893 HEPATIC FUNCTION ABNORMAL 141 0.0038
894 THERAPEUTIC RESPONSE UNEXPECTED 169 0.0038
895 ACUTE KIDNEY INJURY 573 0.0037
896 OVERDOSE 807 0.0037
897 RESTLESS LEGS SYNDROME 68 0.0037
898 ATRIAL FIBRILLATION 362 0.0037
899 HOT FLUSH 279 0.0037
900 OSTEONECROSIS 121 0.0037
901 PAIN OF SKIN 99 0.0037
902 MYELOSUPPRESSION 132 0.0037
903 HYPOACUSIS 157 0.0036
904 CHOLESTASIS 70 0.0036
905 CARDIAC DISORDER 339 0.0036
906 HEPATIC FAILURE 108 0.0036
907 PRODUCT DISPENSING ERROR 78 0.0036
908 HAEMATURIA 122 0.0036
909 SUICIDAL IDEATION 325 0.0035
910 EYE PRURITUS 119 0.0035
911 PRODUCT DOSE OMISSION IN ERROR 100 0.0035
912 NERVOUSNESS 183 0.0035
913 BONE MARROW FAILURE 71 0.0035
914 CEREBROVASCULAR ACCIDENT 590 0.0035
915 TREMOR 572 0.0034
916 EPISTAXIS 254 0.0034
917 DIPLOPIA 88 0.0034
918 RASH GENERALISED 87 0.0034
919 PANIC ATTACK 121 0.0033
920 SPEECH DISORDER 173 0.0033
921 URINARY RETENTION 110 0.0033
922 AGEUSIA 82 0.0033
923 DYSPHAGIA 309 0.0033
924 DISEASE PROGRESSION 381 0.0032
925 RETCHING 66 0.0031
926 PLATELET COUNT DECREASED 326 0.0031
927 URINARY INCONTINENCE 90 0.0030
928 ABASIA 75 0.0030
929 BLOOD CREATINE PHOSPHOKINASE INCREASED 87 0.0030
930 THERAPY INTERRUPTED 215 0.0030
931 EYE IRRITATION 173 0.0030
932 RENAL FAILURE ACUTE 127 0.0030
933 SKIN EXFOLIATION 252 0.0030
934 DEMENTIA 83 0.0030
935 CARDIAC FAILURE CONGESTIVE 232 0.0029
936 NEEDLE ISSUE 83 0.0028
937 METABOLIC ACIDOSIS 91 0.0028
938 DRUG EXPOSURE DURING PREGNANCY 96 0.0028
939 MOOD ALTERED 76 0.0028
940 HYPOXIA 98 0.0028
941 DEVICE MALFUNCTION 193 0.0027
942 BLINDNESS 111 0.0027
943 CEREBRAL INFARCTION 66 0.0027
944 ENCEPHALOPATHY 66 0.0027
945 DEVICE ISSUE 237 0.0026
946 BLOOD BILIRUBIN INCREASED 71 0.0026
947 VISION BLURRED 360 0.0026
948 LACRIMATION INCREASED 79 0.0026
949 NEUTROPHIL COUNT DECREASED 105 0.0026
950 HAEMATOMA 66 0.0025
951 INJECTION SITE MASS 94 0.0025
952 DRY SKIN 338 0.0025
953 MULTIPLE SCLEROSIS 120 0.0025
954 CARDIAC FAILURE 199 0.0025
955 HYPERSOMNIA 71 0.0025
956 PROSTATE CANCER 198 0.0025
957 TOXICITY TO VARIOUS AGENTS 407 0.0024
958 FEBRILE NEUTROPENIA 160 0.0024
959 PRODUCT DOSE OMISSION 155 0.0024
960 PRODUCT SUBSTITUTION ISSUE 134 0.0023
961 RENAL INJURY 68 0.0023
962 DYSARTHRIA 86 0.0023
963 BRADYCARDIA 121 0.0023
964 SEIZURE 259 0.0022
965 WRONG TECHNIQUE IN DRUG USAGE PROCESS 79 0.0022
966 BLOOD GLUCOSE INCREASED 390 0.0021
967 HYPERGLYCAEMIA 74 0.0020
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 143 0.0020
969 HALLUCINATION 147 0.0019
970 THERAPY CESSATION 99 0.0019
971 ANGER 65 0.0019
972 NO ADVERSE EVENT 340 0.0019
973 DISTURBANCE IN ATTENTION 99 0.0018
974 VAGINAL HAEMORRHAGE 79 0.0018
975 DYSKINESIA 73 0.0018
976 COGNITIVE DISORDER 83 0.0018
977 DRUG DOSE OMISSION 280 0.0017
978 AGITATION 122 0.0017
979 DEATH 1316 0.0015
980 EMOTIONAL DISTRESS 182 0.0015
981 CARDIAC ARREST 124 0.0015
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 301 0.0015
983 IRRITABILITY 88 0.0015
984 ACCIDENTAL EXPOSURE TO PRODUCT 150 0.0015
985 HYPOGLYCAEMIA 70 0.0014
986 SKIN BURNING SENSATION 98 0.0014
987 PRODUCT STORAGE ERROR 111 0.0013
988 CONVULSION 70 0.0012
989 DRUG DEPENDENCE 162 0.0010